United States Deferasirox Market by Manufacturers, States, Type and Application, Forecast to 2022

November 2017 | 119 pages | ID: UA8E9D138FDEN
GlobalInfoResearch

Abstracts

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

SCOPE OF THE REPORT:

This report focuses on the Deferasirox in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• Novartis
• Cipla
• Sun Pharma
• Natco Pharma

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• 500 mg/Tablet
• 250 mg/Tablet
• 125 mg/Tablet
• Others

Market Segment by Applications, can be divided into

• Transfusional Iron Overload
• NTDT Caused Iron Overload

There are 17 Chapters to deeply display the United States Deferasirox market.

Chapter 1, to describe Deferasirox Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Deferasirox, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Deferasirox, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Deferasirox market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Deferasirox Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Deferasirox Introduction
1.2 Market Analysis by Type
  1.2.1 500 mg/Tablet
  1.2.2 250 mg/Tablet
  1.2.3 125 mg/Tablet
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Transfusional Iron Overload
  1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Profile
  2.1.2 Deferasirox Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Novartis News
2.2 Cipla
  2.2.1 Profile
  2.2.2 Deferasirox Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Cipla News
2.3 Sun Pharma
  2.3.1 Profile
  2.3.2 Deferasirox Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Sun Pharma News
2.4 Natco Pharma
  2.4.1 Profile
  2.4.2 Deferasirox Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Natco Pharma News

3 UNITED STATES DEFERASIROX MARKET COMPETITION, BY MANUFACTURER

3.1 United States Deferasirox Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Deferasirox Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Deferasirox Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Deferasirox Manufacturer Market Share
  3.4.2 Top 5 Deferasirox Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES DEFERASIROX MARKET ANALYSIS BY STATES

4.1 United States Deferasirox Sales Market Share by States
4.2 United States Deferasirox Sales by States (2012-2017)
4.3 United States Deferasirox Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION DEFERASIROX BY TYPE

5.1 United States Deferasirox Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Deferasirox Sales and Market Share by Type (2012-2017)
  5.1.2 United States Deferasirox Revenue and Market Share by Type (2012-2017)
5.2 500 mg/Tablet Sales Growth and Price
  5.2.1 United States 500 mg/Tablet Sales Growth (2012-2017)
  5.2.2 United States 500 mg/Tablet Price (2012-2017)
5.3 250 mg/Tablet Sales Growth and Price
  5.3.1 United States 250 mg/Tablet Sales Growth (2012-2017)
  5.3.2 United States 250 mg/Tablet Price (2012-2017)
5.4 125 mg/Tablet Sales Growth and Price
  5.4.1 United States 125 mg/Tablet Sales Growth (2012-2017)
  5.4.2 United States 125 mg/Tablet Price (2012-2017)
5.5 Others Sales Growth and Price
  5.5.1 United States Others Sales Growth (2012-2017)
  5.5.2 United States Others Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION DEFERASIROX BY APPLICATION

6.1 United States Deferasirox Sales Market Share by Application (2012-2017)
6.2 Transfusional Iron Overload Sales Growth (2012-2017)
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)

7 CALIFORNIA DEFERASIROX SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Deferasirox Revenue, Sales and Growth Rate (2012-2017)
7.2 California Deferasirox Sales and Market Share by Type
7.3 California Deferasirox Sales by Application (2012-2017)

8 NEW YORK DEFERASIROX SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Deferasirox Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Deferasirox Sales and Market Share by Type
8.3 New York Deferasirox Sales by Application (2012-2017)

9 TEXAS DEFERASIROX SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Deferasirox Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Deferasirox Sales and Market Share by Type
9.3 Texas Deferasirox Sales by Application (2012-2017)

10 FLORIDA DEFERASIROX SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Deferasirox Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Deferasirox Sales and Market Share by Type
10.3 Florida Deferasirox Sales by Application (2012-2017)

11 ILLINOIS DEFERASIROX SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Deferasirox Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Deferasirox Sales and Market Share by Type
11.3 Illinois Deferasirox Sales by Application (2012-2017)

12 DEFERASIROX MARKET FORECAST (2017-2022)

12.1 United States Deferasirox Sales, Revenue and Growth Rate (2017-2022)
12.2 Deferasirox Market Forecast by States (2017-2022)
12.3 Deferasirox Market Forecast by Type (2017-2022)
12.4 Deferasirox Market Forecast by Application (2017-2022)

13 DEFERASIROX MANUFACTURING COST ANALYSIS

13.1 Deferasirox Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Deferasirox

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Deferasirox Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Deferasirox Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Deferasirox Picture
Table Product Specifications of Deferasirox
Figure United States Sales Market Share of Deferasirox by Types in 2016
Table Types of Deferasirox
Figure 500 mg/Tablet Picture
Table Major Manufacturers of 500 mg/Tablet
Figure 250 mg/Tablet Picture
Table Major Manufacturers of 250 mg/Tablet
Figure 125 mg/Tablet Picture
Table Major Manufacturers of 125 mg/Tablet
Figure Others Picture
Table Major Manufacturers of Others
Table United States Deferasirox Sales Market Share by Applications in 2016
Table Applications of Deferasirox
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure California Deferasirox Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Deferasirox Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Deferasirox Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Deferasirox Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Deferasirox Revenue (Million USD) and Growth Rate (2012-2022)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Deferasirox Type and Applications
Table Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Deferasirox Type and Applications
Table Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Deferasirox Type and Applications
Table Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Deferasirox Type and Applications
Table Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Deferasirox Sales by Manufacturer (2016-2017)
Figure United States Deferasirox Sales Market Share by Manufacturer in 2016
Figure United States Deferasirox Sales Market Share by Manufacturer in 2017
Table United States Deferasirox Revenue by Manufacturer (2016-2017)
Figure United States Deferasirox Revenue Market Share by Manufacturer in 2015
Figure United States Deferasirox Revenue Market Share by Manufacturer in 2016
Table United States Deferasirox Price by Manufacturers (2016-2017)
Figure Top 3 Deferasirox Manufacturer Market Share in 2016
Figure Top 3 Deferasirox Manufacturer Market Share in 2017
Figure Top 5 Deferasirox Manufacturer Market Share in 2016
Figure Top 5 Deferasirox Manufacturer Market Share in 2017
Figure United States Deferasirox Sales and Growth (2012-2017)
Table United States Deferasirox Sales by States (2012-2017)
Table United States Deferasirox Sales Market Share by States (2012-2017)
Figure United States 2012 Deferasirox Sales Market Share by States
Figure United States 2016 Deferasirox Sales Market Share by States
Figure United States Deferasirox Revenue and Growth (2012-2017)
Table United States Deferasirox Revenue by States (2012-2017)
Table United States Deferasirox Revenue Market Share by States (2012-2017)
Table United States 2012 Deferasirox Revenue Market Share by States
Table United States 2016 Deferasirox Revenue Market Share by States
Table United States Deferasirox Sales by Type (2012-2017)
Table United States Deferasirox Sales Share by Type (2012-2017)
Table United States Deferasirox Revenue by Type (2012-2017)
Table United States Deferasirox Revenue Share by Type (2012-2017)
Figure United States 500 mg/Tablet Sales Growth (2012-2017)
Figure United States 500 mg/Tablet Price (2012-2017)
Figure United States 250 mg/Tablet Sales Growth (2012-2017)
Figure United States 250 mg/Tablet Price (2012-2017)
Figure United States 125 mg/Tablet Sales Growth (2012-2017)
Figure United States 125 mg/Tablet Price (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure United States Others Price (2012-2017)
Table United States Deferasirox Sales by Application (2012-2017)
Table United States Deferasirox Sales Share by Application (2012-2017)
Figure United States Transfusional Iron Overload Sales Growth (2012-2017)
Figure United States NTDT Caused Iron Overload Sales Growth (2012-2017)
Figure California Deferasirox Revenue and Growth (2012-2017)
Figure California Deferasirox Sales and Growth (2012-2017)
Table California Deferasirox Sales by Type (2012-2017)
Table California Deferasirox Sales Market Share by Type (2012-2017)
Table California Deferasirox Sales by Application (2012-2017)
Table California Deferasirox Sales Market Share by Application (2012-2017)
Figure New York Deferasirox Revenue and Growth (2012-2017)
Figure New York Deferasirox Sales and Growth (2012-2017)
Table New York Deferasirox Sales by Type (2012-2017)
Table New York Deferasirox Sales Market Share by Type (2012-2017)
Table New York Deferasirox Sales by Application (2012-2017)
Table New York Deferasirox Sales Market Share by Application (2012-2017)
Figure Texas Deferasirox Revenue and Growth (2012-2017)
Figure Texas Deferasirox Sales and Growth (2012-2017)
Table Texas Deferasirox Sales by Type (2012-2017)
Table Texas Deferasirox Sales Market Share by Type (2012-2017)
Table Texas Deferasirox Sales by Application (2012-2017)
Table Texas Deferasirox Sales Market Share by Application (2012-2017)
Figure Florida Deferasirox Revenue and Growth (2012-2017)
Figure Florida Deferasirox Sales and Growth (2012-2017)
Table Florida Deferasirox Sales by Type (2012-2017)
Table Florida Deferasirox Sales Market Share by Type (2012-2017)
Table Florida Deferasirox Sales by Application (2012-2017)
Table Florida Deferasirox Sales Market Share by Application (2012-2017)
Figure Illinois Deferasirox Revenue and Growth (2012-2017)
Figure Illinois Deferasirox Sales and Growth (2012-2017)
Table Illinois Deferasirox Sales by Type (2012-2017)
Table Illinois Deferasirox Sales Market Share by Type (2012-2017)
Table Illinois Deferasirox Sales by Application (2012-2017)
Table Illinois Deferasirox Sales Market Share by Application (2012-2017)
Figure United States Deferasirox Sales, Revenue and Growth Rate (2017-2022)
Table United States Deferasirox Sales Forecast by States (2017-2022)
Table United States Deferasirox Market Share Forecast by States (2017-2022)
Table United States Deferasirox Sales Forecast by Type (2017-2022)
Table United States Deferasirox Market Share Forecast by Type (2017-2022)
Table United States Deferasirox Sales Forecast by Application (2017-2022)
Table United States Deferasirox Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Deferasirox
Figure Manufacturing Process Analysis of Deferasirox
Figure Deferasirox Industrial Chain Analysis
Table Raw Materials Sources of Deferasirox Major Manufacturers in 2016
Table Major Buyers of Deferasirox
Table Distributors/Traders/ Dealers List